-
1
-
-
0036716281
-
The Bcl2 family: Regulators of the cellular life-or-death switch
-
Cory, S. and Adams, J. M. (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2(9), 647-656.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.9
, pp. 647-656
-
-
Cory, S.1
Adams, J.M.2
-
2
-
-
0036463405
-
A matter of life and death
-
Green, D. R. and Evan, G. I. (2002). A matter of life and death. Cancer Cell 1(1), 19-30.
-
(2002)
Cancer Cell
, vol.1
, Issue.1
, pp. 19-30
-
-
Green, D.R.1
Evan, G.I.2
-
3
-
-
9244224723
-
Intrinsic tumour suppression
-
Lowe, S. W., Cepero, E., and Evans, G. (2004). Intrinsic tumour suppression. Nature 432, 307-315.
-
(2004)
Nature
, vol.432
, pp. 307-315
-
-
Lowe, S.W.1
Cepero, E.2
Evans, G.3
-
4
-
-
0034602188
-
Role of BAX in the apoptotic response to anticancer agents
-
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., and Vogelstein, B. (2000). Role of BAX in the apoptotic response to anticancer agents. Science 290(5493), 989-992.
-
(2000)
Science
, vol.290
, Issue.5493
, pp. 989-992
-
-
Zhang, L.1
Yu, J.2
Park, B.H.3
Kinzler, K.W.4
Vogelstein, B.5
-
5
-
-
0036721455
-
Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia
-
Bellosillo, B., Villamor, N., Lopez-Guillermo, A., Marce, S., Bosch, F., Campo, E., Montserrat, E., and Colomer, D. (2002). Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Blood 100(5), 1810-1816.
-
(2002)
Blood
, vol.100
, Issue.5
, pp. 1810-1816
-
-
Bellosillo, B.1
Villamor, N.2
Lopez-Guillermo, A.3
Marce, S.4
Bosch, F.5
Campo, E.6
Montserrat, E.7
Colomer, D.8
-
6
-
-
0036141029
-
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO
-
Deng, Y., Lin, Y., and Wu, X. (2002). TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16, 33-45.
-
(2002)
Genes Dev
, vol.16
, pp. 33-45
-
-
Deng, Y.1
Lin, Y.2
Wu, X.3
-
7
-
-
0035229427
-
The mitochondrion in apoptosis: How Pandora's box opens
-
Zamzami, N. and Kroemer, G. (2001). The mitochondrion in apoptosis: how Pandora's box opens. Mol Cell Biol 2, 67-71.
-
(2001)
Mol Cell Biol
, vol.2
, pp. 67-71
-
-
Zamzami, N.1
Kroemer, G.2
-
8
-
-
0036097786
-
Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins
-
Puthalakath, H. and Strasser, A. (2002). Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9(5), 505-512.
-
(2002)
Cell Death Differ
, vol.9
, Issue.5
, pp. 505-512
-
-
Puthalakath, H.1
Strasser, A.2
-
9
-
-
27544446991
-
Life in the balance: How BH3-only proteins induce apoptosis
-
Willis, S. N. and Adams, J. M. (2005). Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17, 617-625.
-
(2005)
Curr Opin Cell Biol
, vol.17
, pp. 617-625
-
-
Willis, S.N.1
Adams, J.M.2
-
10
-
-
0036728834
-
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
-
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S. and Korsmeyer, S. J. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2(3), 183-192.
-
(2002)
Cancer Cell
, vol.2
, Issue.3
, pp. 183-192
-
-
Letai, A.1
Bassik, M.C.2
Walensky, L.D.3
Sorcinelli, M.D.4
Weiler, S.5
Korsmeyer, S.J.6
-
11
-
-
0141629530
-
Granzyme B: Pro-apoptotic, antiviral and antitumor functions
-
Trapani, J. A. and Sutton, V. R. (2003). Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 15(5), 533-543.
-
(2003)
Curr Opin Immunol
, vol.15
, Issue.5
, pp. 533-543
-
-
Trapani, J.A.1
Sutton, V.R.2
-
12
-
-
23044469708
-
Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL
-
Ley, R., Hadfield, K., Howes, E., and Cook, S. J. (2005). Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL. J Biol Chem 280(18), 17657-17663.
-
(2005)
J Biol Chem
, vol.280
, Issue.18
, pp. 17657-17663
-
-
Ley, R.1
Hadfield, K.2
Howes, E.3
Cook, S.J.4
-
13
-
-
1542275411
-
Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover
-
Ley, R., Ewings, K. E., Hadfield, K., Howes, E., Balmanno, K., and Cook, S. J. (2004). Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem 279(10), 8837-8847.
-
(2004)
J Biol Chem
, vol.279
, Issue.10
, pp. 8837-8847
-
-
Ley, R.1
Ewings, K.E.2
Hadfield, K.3
Howes, E.4
Balmanno, K.5
Cook, S.J.6
-
14
-
-
0035823238
-
-
2001
-
Puthalakath, H., Villunger, A., O'Reilly, L. A., Beaumont, J. G., Coultas, L., Cheney, R. E., Huang, D. C. and Strasser, A. (2001). Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis, Science 293(5536), 1829-1832.
-
(1829)
Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis, Science
, vol.293
, Issue.5536
-
-
Puthalakath, H.1
Villunger, A.2
O'Reilly, L.A.3
Beaumont, J.G.4
Coultas, L.5
Cheney, R.E.6
Huang, D.C.7
Strasser, A.8
-
15
-
-
20344398190
-
G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression
-
Collins, N. L., Reginato, M. J., Paulus, J. K., Sgroi, D. C., Labaer, J., and Brugge, J. S. (2005). G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol Cell Biol 25(12), 5282-5291.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.12
, pp. 5282-5291
-
-
Collins, N.L.1
Reginato, M.J.2
Paulus, J.K.3
Sgroi, D.C.4
Labaer, J.5
Brugge, J.S.6
-
16
-
-
24644436766
-
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53
-
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., and Green, D. R. (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309(5741), 1732-1735.
-
(2005)
Science
, vol.309
, Issue.5741
, pp. 1732-1735
-
-
Chipuk, J.E.1
Bouchier-Hayes, L.2
Kuwana, T.3
Newmeyer, D.D.4
Green, D.R.5
-
17
-
-
2342553892
-
Mitochondrial p53 activates Bak and causes disruption of Bak-Mcl1 complex
-
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E. and George, D. L. (2004). Mitochondrial p53 activates Bak and causes disruption of Bak-Mcl1 complex. Nat Cell Biol 6, 443-450.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 443-450
-
-
Leu, J.I.-J.1
Dumont, P.2
Hafey, M.3
Murphy, M.E.4
George, D.L.5
-
18
-
-
27544486327
-
Transcription-independent proapoptotic function of p53
-
Moll, U. M., Wolff, S., Speidel, D., and Deppert, W. (2005). Transcription-independent proapoptotic function of p53. Curr Opin Cell Biol 17(6), 631-636.
-
(2005)
Curr Opin Cell Biol
, vol.17
, Issue.6
, pp. 631-636
-
-
Moll, U.M.1
Wolff, S.2
Speidel, D.3
Deppert, W.4
-
19
-
-
19944432123
-
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
-
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17(3), 393-403.
-
(2005)
Mol Cell
, vol.17
, Issue.3
, pp. 393-403
-
-
Chen, L.1
Willis, S.N.2
Wei, A.3
Smith, B.J.4
Fletcher, J.I.5
Hinds, M.G.6
Colman, P.M.7
Day, C.L.8
Adams, J.M.9
Huang, D.C.10
-
20
-
-
22244454745
-
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: Therapeutic implications
-
Fernandez, Y., Verhagen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W., Jr., Lowe, S. W. and Soengas, M. S. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65(14), 6294-6304.
-
(2005)
Cancer Res
, vol.65
, Issue.14
, pp. 6294-6304
-
-
Fernandez, Y.1
Verhagen, M.2
Miller, T.P.3
Rush, J.L.4
Steiner, P.5
Opipari Jr., A.W.6
Lowe, S.W.7
Soengas, M.S.8
-
21
-
-
4444303958
-
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas
-
Qin, J. Z., Stennett, L., Bacon, P., Bodner, B., Hendrix, M. J., Seftor, R. E., Seftor, E. A., Margaryan, N. V., Pollock, P. M., Curtis, A., Trent, J. M., Bennett, F., Miele, L., and Nickoloff, B. J. (2004). p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther 3(8), 895-902.
-
(2004)
Mol Cancer Ther
, vol.3
, Issue.8
, pp. 895-902
-
-
Qin, J.Z.1
Stennett, L.2
Bacon, P.3
Bodner, B.4
Hendrix, M.J.5
Seftor, R.E.6
Seftor, E.A.7
Margaryan, N.V.8
Pollock, P.M.9
Curtis, A.10
Trent, J.M.11
Bennett, F.12
Miele, L.13
Nickoloff, B.J.14
-
22
-
-
2442453730
-
The PIDDosome: A protein complex implicated in activation of caspase-2 in response to genotoxic stress
-
Tinel, A. and Tschopp, J. (2004). The PIDDosome: a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304(5672), 843-846.
-
(2004)
Science
, vol.304
, Issue.5672
, pp. 843-846
-
-
Tinel, A.1
Tschopp, J.2
-
23
-
-
33644663668
-
Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis
-
Gao, Z., Shao, Y., and Jiang, X. (2005). Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis. J Biol Chem 280(46), 38271-38275.
-
(2005)
J Biol Chem
, vol.280
, Issue.46
, pp. 38271-38275
-
-
Gao, Z.1
Shao, Y.2
Jiang, X.3
-
25
-
-
27144512715
-
Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8
-
Shin, S., Lee, Y., Kim, W., Ko, H., Choi, H., and Kim, K. (2005). Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24, 3532-3542.
-
(2005)
EMBO J
, vol.24
, pp. 3532-3542
-
-
Shin, S.1
Lee, Y.2
Kim, W.3
Ko, H.4
Choi, H.5
Kim, K.6
-
26
-
-
0032522738
-
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
-
Deveraux, Q. L., Roy, N., Stennicke, H. R., Van Arsdale, T., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesen, G. S., and Reed, J. C. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17(8), 2215-2223.
-
(1998)
EMBO J
, vol.17
, Issue.8
, pp. 2215-2223
-
-
Deveraux, Q.L.1
Roy, N.2
Stennicke, H.R.3
Van Arsdale, T.4
Zhou, Q.5
Srinivasula, S.M.6
Alnemri, E.S.7
Salvesen, G.S.8
Reed, J.C.9
-
27
-
-
0034921727
-
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs
-
Verhagen, A. M., Coulson, E. J. and Vaux, D. L. (2001). Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2(7), 3009.1-3009.10.
-
(2001)
Genome Biol
, vol.2
, Issue.7
-
-
Verhagen, A.M.1
Coulson, E.J.2
Vaux, D.L.3
-
28
-
-
5644259587
-
Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice
-
Schimmer, A. D. (2004). Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64(20), 7183-7190.
-
(2004)
Cancer Res
, vol.64
, Issue.20
, pp. 7183-7190
-
-
Schimmer, A.D.1
-
29
-
-
17144377113
-
IAPs, RINGs and ubiquitylation
-
Vaux, D. L. and Silke, J. (2005). IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6(4), 287-297.
-
(2005)
Nat Rev Mol Cell Biol
, vol.6
, Issue.4
, pp. 287-297
-
-
Vaux, D.L.1
Silke, J.2
-
30
-
-
0035476255
-
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria
-
Zhang, X. D., Zhang, X. Y., Gray, C. P., Nguyen, T., and Hersey, P. (2001). Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res 61(19), 7339-7348.
-
(2001)
Cancer Res
, vol.61
, Issue.19
, pp. 7339-7348
-
-
Zhang, X.D.1
Zhang, X.Y.2
Gray, C.P.3
Nguyen, T.4
Hersey, P.5
-
31
-
-
9244239811
-
G1 cell-cycle control and cancer
-
Massague, J. (2004). G1 cell-cycle control and cancer. Nature 432, 298-306.
-
(2004)
Nature
, vol.432
, pp. 298-306
-
-
Massague, J.1
-
32
-
-
18444374405
-
-
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W. C., Leung, S. Y., Yen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
-
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W. C., Leung, S. Y., Yen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
-
-
-
-
33
-
-
2942533921
-
Microarray expression profiling in melanoma reveals a BRAF mutation signature
-
Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, P. M., Walker, G. J., Boyle, G. M., Harper, U., Cozzi, S. J., Hansen, K., Yudt, L., Schmidt, C., Hersey, P., Ellem, K. A. O., O'Rourke, M. G. E., Parsons, P. G., Meltzer, P., Ringner, M., and Hayward, N. K. (2004). Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23, 4060-4067.
-
(2004)
Oncogene
, vol.23
, pp. 4060-4067
-
-
Pavey, S.1
Johansson, P.2
Packer, L.3
Taylor, J.4
Stark, M.5
Pollock, P.M.6
Walker, G.J.7
Boyle, G.M.8
Harper, U.9
Cozzi, S.J.10
Hansen, K.11
Yudt, L.12
Schmidt, C.13
Hersey, P.14
Ellem, K.A.O.15
O'Rourke, M.G.E.16
Parsons, P.G.17
Meltzer, P.18
Ringner, M.19
Hayward, N.K.20
more..
-
34
-
-
0037228055
-
High frequency of BRAF mutations in nevi
-
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N. K., Trent, J. M., and Meltzer, P. S. (2003). High frequency of BRAF mutations in nevi. Nat Genet 33(1), 19-20.
-
(2003)
Nat Genet
, vol.33
, Issue.1
, pp. 19-20
-
-
Pollock, P.M.1
Harper, U.L.2
Hansen, K.S.3
Yudt, L.M.4
Stark, M.5
Robbins, C.M.6
Moses, T.Y.7
Hostetter, G.8
Wagner, U.9
Kakareka, J.10
Salem, G.11
Pohida, T.12
Heenan, P.13
Duray, P.14
Kallioniemi, O.15
Hayward, N.K.16
Trent, J.M.17
Meltzer, P.S.18
-
35
-
-
23244447037
-
BRAFE600-associated senescence-like cell cycle arrest of human naevi
-
Michaloglou, C., Vredeveld, L. C., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M., Majoor, D. M., Shay, J. W., Mooi, W. J., and Peeper, D. S. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436(7051), 720-724.
-
(2005)
Nature
, vol.436
, Issue.7051
, pp. 720-724
-
-
Michaloglou, C.1
Vredeveld, L.C.2
Soengas, M.S.3
Denoyelle, C.4
Kuilman, T.5
van der Horst, C.M.6
Majoor, D.M.7
Shay, J.W.8
Mooi, W.J.9
Peeper, D.S.10
-
36
-
-
27844567142
-
Distinct sets of genetic alterations in melanoma
-
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K. H., Aiba, S., Brocker, E. B., LeBoit, P. E., Pinkel, D., and Bastian, B. C. (2005). Distinct sets of genetic alterations in melanoma. N Engl J Med 353(20), 2104-2107.
-
(2005)
N Engl J Med
, vol.353
, Issue.20
, pp. 2104-2107
-
-
Curtin, J.A.1
Fridlyand, J.2
Kageshita, T.3
Patel, H.N.4
Busam, K.J.5
Kutzner, H.6
Cho, K.H.7
Aiba, S.8
Brocker, E.B.9
LeBoit, P.E.10
Pinkel, D.11
Bastian, B.C.12
-
37
-
-
16644400331
-
Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas
-
Bachmann, I. M., Straume, O. and Akslen, L. A. (2004). Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. Int J Oncol 25(6), 1559-1565.
-
(2004)
Int J Oncol
, vol.25
, Issue.6
, pp. 1559-1565
-
-
Bachmann, I.M.1
Straume, O.2
Akslen, L.A.3
-
38
-
-
21544447829
-
Rb/E2F: A two-edged sword in the melanocytic system
-
Halaban, R. (2005). Rb/E2F: a two-edged sword in the melanocytic system. Cancer Metastasis Rev 24(2), 339-356.
-
(2005)
Cancer Metastasis Rev
, vol.24
, Issue.2
, pp. 339-356
-
-
Halaban, R.1
-
39
-
-
13844312037
-
Cutaneous melanoma
-
Thompson, J. F., Scolyer, R. A., and Kefford, R. F. (2005). Cutaneous melanoma. Lancet 365, 687-701.
-
(2005)
Lancet
, vol.365
, pp. 687-701
-
-
Thompson, J.F.1
Scolyer, R.A.2
Kefford, R.F.3
-
40
-
-
0028348001
-
Mutation and expression of the p53 gene in human malignant melanoma
-
Albino, A. P., Vidal, M. J., McNutt, N. S., Shea, C. R., Prieto, V. G., Nanus, D. M., Palmer, J. M., and Hayward, N. K. (1994). Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 4, 35-45.
-
(1994)
Melanoma Res
, vol.4
, pp. 35-45
-
-
Albino, A.P.1
Vidal, M.J.2
McNutt, N.S.3
Shea, C.R.4
Prieto, V.G.5
Nanus, D.M.6
Palmer, J.M.7
Hayward, N.K.8
-
41
-
-
4043181214
-
Cancer genes and the pathways they control
-
Vogelstein, B. and Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nat Med 10(8), 789-799.
-
(2004)
Nat Med
, vol.10
, Issue.8
, pp. 789-799
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
42
-
-
0032998108
-
p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis
-
Zerp, S. F., van Elsas, A., Peltenburg, L. T. C., and Schrier, P. I. (1999). p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Brit J Cancer 79, 921-926.
-
(1999)
Brit J Cancer
, vol.79
, pp. 921-926
-
-
Zerp, S.F.1
van Elsas, A.2
Peltenburg, L.T.C.3
Schrier, P.I.4
-
43
-
-
0031821605
-
p53 expression and risk factors for cutaneous melanoma: A case-control study
-
Whiteman, D. C., Parsons, P. G., and Green, A. C. (1998). p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 77(6), 843-848.
-
(1998)
Int J Cancer
, vol.77
, Issue.6
, pp. 843-848
-
-
Whiteman, D.C.1
Parsons, P.G.2
Green, A.C.3
-
44
-
-
26444575417
-
Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma
-
Purdue, M. P., From, L., Kahn, H. J., Armstrong, B. K., Kricker, A., Gallagher, R. P., McLaughlin, J. R., Klar, N. S. and Marrett, L. D. (2005). Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int J Cancer 117, 486-493.
-
(2005)
Int J Cancer
, vol.117
, pp. 486-493
-
-
Purdue, M.P.1
From, L.2
Kahn, H.J.3
Armstrong, B.K.4
Kricker, A.5
Gallagher, R.P.6
McLaughlin, J.R.7
Klar, N.S.8
Marrett, L.D.9
-
45
-
-
0033795383
-
Aberrant regulation and function of Wild-type p53 in radioresistant melanoma cells
-
Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., el-Deiry, W. S., Herlyn, M., and Halazonetis, T. D. (2000). Aberrant regulation and function of Wild-type p53 in radioresistant melanoma cells. Cell Growth Differ 11, 467-474.
-
(2000)
Cell Growth Differ
, vol.11
, pp. 467-474
-
-
Satyamoorthy, K.1
Chehab, N.H.2
Waterman, M.J.F.3
Lien, M.C.4
el-Deiry, W.S.5
Herlyn, M.6
Halazonetis, T.D.7
-
46
-
-
4444351219
-
Regulation of human p53 activity and cell localization by alternative splicing
-
Ghosh, A., Stewart, D., and Matlashewski, G. (2004). Regulation of human p53 activity and cell localization by alternative splicing, Mol Cell Biol 24(18), 7987-7997.
-
(2004)
Mol Cell Biol
, vol.24
, Issue.18
, pp. 7987-7997
-
-
Ghosh, A.1
Stewart, D.2
Matlashewski, G.3
-
47
-
-
64549157132
-
-
in preparation
-
Zhuang, L. (2006) (in preparation).
-
(2006)
-
-
Zhuang, L.1
-
48
-
-
18644380911
-
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
-
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., and Yu, H. (2002). Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 21(46), 7001-7010.
-
(2002)
Oncogene
, vol.21
, Issue.46
, pp. 7001-7010
-
-
Niu, G.1
Bowman, T.2
Huang, M.3
Shivers, S.4
Reintgen, D.5
Daud, A.6
Chang, A.7
Kraker, A.8
Jove, R.9
Yu, H.10
-
49
-
-
20844444135
-
Targeting Stat3 in cancer therapy
-
Jing, N. and Tweardy, D. J. (2005). Targeting Stat3 in cancer therapy. Anticancer Drugs 16(6), 601-607.
-
(2005)
Anticancer Drugs
, vol.16
, Issue.6
, pp. 601-607
-
-
Jing, N.1
Tweardy, D.J.2
-
50
-
-
20444452357
-
Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells
-
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., and Gores, G. J. (2005). Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 128(7), 2054-2065.
-
(2005)
Gastroenterology
, vol.128
, Issue.7
, pp. 2054-2065
-
-
Kobayashi, S.1
Werneburg, N.W.2
Bronk, S.F.3
Kaufmann, S.H.4
Gores, G.J.5
-
51
-
-
27144502652
-
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006
-
Yu, C., Bruzek, L. M., Meng, X. W., Gores, G. J., Carter, C. A., Kaufmann, S. H. and Adjei, A. A. (2005). The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006. Oncogene 24(46), 6861-6869.
-
(2005)
Oncogene
, vol.24
, Issue.46
, pp. 6861-6869
-
-
Yu, C.1
Bruzek, L.M.2
Meng, X.W.3
Gores, G.J.4
Carter, C.A.5
Kaufmann, S.H.6
Adjei, A.A.7
-
52
-
-
21244472965
-
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
-
Zhong, Q., Gao, W., Du, F., and Wang, X. (2005). Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121(7), 1085-1095.
-
(2005)
Cell
, vol.121
, Issue.7
, pp. 1085-1095
-
-
Zhong, Q.1
Gao, W.2
Du, F.3
Wang, X.4
-
53
-
-
21244498122
-
Life, death, and ubiquitin: Taming the mule
-
Shmueli A. and Oren, M. (2005). Life, death, and ubiquitin: taming the mule. Cell 121(7), 963-965.
-
(2005)
Cell
, vol.121
, Issue.7
, pp. 963-965
-
-
Shmueli, A.1
Oren, M.2
-
54
-
-
18444418797
-
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability
-
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., and Fisher, D. E. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
-
(2002)
Cell
, vol.109
, pp. 707-718
-
-
McGill, G.G.1
Horstmann, M.2
Widlund, H.R.3
Du, J.4
Motyckova, G.5
Nishimura, E.K.6
Lin, Y.L.7
Ramaswamy, S.8
Avery, W.9
Ding, H.F.10
Jordan, S.A.11
Jackson, I.J.12
Korsmeyer, S.J.13
Golub, T.R.14
Fisher, D.E.15
-
55
-
-
23744513041
-
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: A retrospective stud of 261 patients
-
Janku, F., Novotny, J., Julis, I., Julisova, I., Pecen, L., Tomancova, V., Kocmanova, G., Krasna, L., Krajsova, I., Stork, J., and Petruzelka, L. (2005). KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective stud of 261 patients. Melanoma Res 15(4), 251-256.
-
(2005)
Melanoma Res
, vol.15
, Issue.4
, pp. 251-256
-
-
Janku, F.1
Novotny, J.2
Julis, I.3
Julisova, I.4
Pecen, L.5
Tomancova, V.6
Kocmanova, G.7
Krasna, L.8
Krajsova, I.9
Stork, J.10
Petruzelka, L.11
-
56
-
-
20144386401
-
Regulation of gene expression in melanoma: New approaches for treatment
-
Leslie, M. C. and Bar-Eli, M. (2005). Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem 94(1), 25-38.
-
(2005)
J Cell Biochem
, vol.94
, Issue.1
, pp. 25-38
-
-
Leslie, M.C.1
Bar-Eli, M.2
-
57
-
-
0031763526
-
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma
-
Karjalainen, J. M., Kellokoski, J. K., Eskelinen, M. J., Alhava, E. M., and Kosma, V. M. (1998). Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol 16(11), 3584-3591.
-
(1998)
J Clin Oncol
, vol.16
, Issue.11
, pp. 3584-3591
-
-
Karjalainen, J.M.1
Kellokoski, J.K.2
Eskelinen, M.J.3
Alhava, E.M.4
Kosma, V.M.5
-
58
-
-
0037160111
-
Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53
-
McPherson, L. A., Loktev, A. V., and Weigel, R. J. (2002). Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J Biol Chem 277(47), 45028-45033.
-
(2002)
J Biol Chem
, vol.277
, Issue.47
, pp. 45028-45033
-
-
McPherson, L.A.1
Loktev, A.V.2
Weigel, R.J.3
-
59
-
-
0037400975
-
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
-
Smalley, K. S. M. (2003). A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer 104, 527-532.
-
(2003)
Int J Cancer
, vol.104
, pp. 527-532
-
-
Smalley, K.S.M.1
-
60
-
-
64549150781
-
Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/ DIABLO release from mitochondria
-
Zhang, X. D., Borrow, J. M., Zhang, X. Y., Nguyen, T., and Hersey, P. (2003). Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/ DIABLO release from mitochondria. Oncogene 222, 869-2881.
-
(2003)
Oncogene
, vol.222
, pp. 869-2881
-
-
Zhang, X.D.1
Borrow, J.M.2
Zhang, X.Y.3
Nguyen, T.4
Hersey, P.5
-
61
-
-
0034618369
-
MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL and Mcl-1 and promotes survival of human pancreatic cancer cells
-
Boucher, M.-J., Morisset, J., Vachon, P. H., Reed, J. C., Laine, J., and Rivard, N. (2000). MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biol 79, 355-369.
-
(2000)
J Cell Biol
, vol.79
, pp. 355-369
-
-
Boucher, M.-J.1
Morisset, J.2
Vachon, P.H.3
Reed, J.C.4
Laine, J.5
Rivard, N.6
-
62
-
-
24044543035
-
Activation of the extracellular-signal related kinase (ERK) pathway in human melanoma
-
Zhuang, L., Lee, C. S., Scolyer, R. A., McCarthy, S. W., Palmer, A. A., Zhang, X. D., Thompson, J. F., Bron, L. P. and Hersey, P. (2005). Activation of the extracellular-signal related kinase (ERK) pathway in human melanoma. J Clin Pathol 58(11), 1163-1169.
-
(2005)
J Clin Pathol
, vol.58
, Issue.11
, pp. 1163-1169
-
-
Zhuang, L.1
Lee, C.S.2
Scolyer, R.A.3
McCarthy, S.W.4
Palmer, A.A.5
Zhang, X.D.6
Thompson, J.F.7
Bron, L.P.8
Hersey, P.9
-
63
-
-
0038660702
-
Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling
-
Govindarajan, B., Bai, X., Cohen, C., Zhong, H., Kilroy, S., Louis, G., Moses, M., and Arbiser, J. L. (2003). Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J Biol Chem 278(11), 9790-9795.
-
(2003)
J Biol Chem
, vol.278
, Issue.11
, pp. 9790-9795
-
-
Govindarajan, B.1
Bai, X.2
Cohen, C.3
Zhong, H.4
Kilroy, S.5
Louis, G.6
Moses, M.7
Arbiser, J.L.8
-
64
-
-
31144453233
-
BRAF mutation predicts sensitivity to MEK inhibition
-
Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, M., She, Y., Osman, I., Golub, T. R., Sebolt-Leopold, J., Sellers, W. R. and Rosen, N. (2006). BRAF mutation predicts sensitivity to MEK inhibition. Nature 439, 358-362.
-
(2006)
Nature
, vol.439
, pp. 358-362
-
-
Solit, D.B.1
Garraway, L.A.2
Pratilas, C.A.3
Sawai, A.4
Getz, G.5
Basso, A.6
Ye, Q.7
Lobo, M.8
She, Y.9
Osman, I.10
Golub, T.R.11
Sebolt-Leopold, J.12
Sellers, W.R.13
Rosen, N.14
-
66
-
-
0034744538
-
Induction of ?3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway
-
Woods, D., Cherwinski, H., Venetsanakos, E., Bhat, A., Gysin, S., Humbert, M., Bray, P. F., Saylor, V. L., and McMahon, M. (2001). Induction of ?3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol 21(9), 3192-3205.
-
(2001)
Mol Cell Biol
, vol.21
, Issue.9
, pp. 3192-3205
-
-
Woods, D.1
Cherwinski, H.2
Venetsanakos, E.3
Bhat, A.4
Gysin, S.5
Humbert, M.6
Bray, P.F.7
Saylor, V.L.8
McMahon, M.9
-
67
-
-
0035897407
-
Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1
-
Aplin, A. E., Stewart, S. A., Assoian, R. K., and Juliano, R. L. (2001). Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol 153(2), 273-282.
-
(2001)
J Cell Biol
, vol.153
, Issue.2
, pp. 273-282
-
-
Aplin, A.E.1
Stewart, S.A.2
Assoian, R.K.3
Juliano, R.L.4
-
68
-
-
23044514254
-
Regulatory phosphorylation of Bim: Sorting out the ERK from the JNK
-
Ley, R., Ewings, K. E., Hadfield, K., and Cook, S. J. (2005). Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12, 1008-1014.
-
(2005)
Cell Death Differ
, vol.12
, pp. 1008-1014
-
-
Ley, R.1
Ewings, K.E.2
Hadfield, K.3
Cook, S.J.4
-
69
-
-
0033556387
-
Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation
-
Townsend, K. J., Zhou, P., Qian, L., Bieszczad, C. K., Lowrey, C. H., Yen, A., and Craig, R. W. (1999). Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J Biol Chem 274(3), 1801-1813.
-
(1999)
J Biol Chem
, vol.274
, Issue.3
, pp. 1801-1813
-
-
Townsend, K.J.1
Zhou, P.2
Qian, L.3
Bieszczad, C.K.4
Lowrey, C.H.5
Yen, A.6
Craig, R.W.7
-
70
-
-
24144477947
-
Elevated expression of MITF counteracts B-RAFstimulated melanocyte and melanoma cell proliferation
-
Wellbrock, C. and Marais, R. (2005). Elevated expression of MITF counteracts B-RAFstimulated melanocyte and melanoma cell proliferation. J Cell Biol 170(5), 703-708.
-
(2005)
J Cell Biol
, vol.170
, Issue.5
, pp. 703-708
-
-
Wellbrock, C.1
Marais, R.2
-
71
-
-
21544483506
-
Functional and therapeutic significance of Akt deregulation in malignant melanoma
-
Robertson, G. P. (2005). Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev 24(2), 273-285.
-
(2005)
Cancer Metastasis Rev
, vol.24
, Issue.2
, pp. 273-285
-
-
Robertson, G.P.1
-
72
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex
-
Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science 307, 1098-1101.
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
73
-
-
14944352371
-
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
-
Dai, D. L., Martinka, M., and Li, G. (2005). Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol 23(7), 1473-1482.
-
(2005)
J Clin Oncol
, vol.23
, Issue.7
, pp. 1473-1482
-
-
Dai, D.L.1
Martinka, M.2
Li, G.3
-
74
-
-
0035499454
-
Ten years of protein kinase B signalling: A hard Akt to follow
-
Brazil, D. P. and Hemmings, B. A. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26(11), 657-664.
-
(2001)
Trends Biochem Sci
, vol.26
, Issue.11
, pp. 657-664
-
-
Brazil, D.P.1
Hemmings, B.A.2
-
75
-
-
21544454681
-
Role of nuclear factor-kB in melanoma
-
Amiri, K. I. and Richmond, A. (2005). Role of nuclear factor-kB in melanoma. Cancer Metastasis Rev 24, 301-313.
-
(2005)
Cancer Metastasis Rev
, vol.24
, pp. 301-313
-
-
Amiri, K.I.1
Richmond, A.2
-
76
-
-
23844445836
-
Colorectal cancer: Mutations in a signalling pathway
-
Parsons, D. W., Wang, T. L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., Markowitz, S., Kinzler, K. W., Vogelstein, B., Lengauer, C., and Velculescu, V. E. (2005). Colorectal cancer: mutations in a signalling pathway. Nature 436(7052), 792.
-
(2005)
Nature
, vol.436
, Issue.7052
, pp. 792
-
-
Parsons, D.W.1
Wang, T.L.2
Samuels, Y.3
Bardelli, A.4
Cummins, J.M.5
DeLong, L.6
Silliman, N.7
Ptak, J.8
Szabo, S.9
Willson, J.K.V.10
Markowitz, S.11
Kinzler, K.W.12
Vogelstein, B.13
Lengauer, C.14
Velculescu, V.E.15
-
77
-
-
0036933371
-
PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines
-
Pollock, P. M., Walker, G. J., Glendening, J. M., Que Noy, T., Bloch, N. C., Fountain, J. W., and Hayward, N. K. (2002). PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Melanoma Res 12(6), 565-575.
-
(2002)
Melanoma Res
, vol.12
, Issue.6
, pp. 565-575
-
-
Pollock, P.M.1
Walker, G.J.2
Glendening, J.M.3
Que Noy, T.4
Bloch, N.C.5
Fountain, J.W.6
Hayward, N.K.7
-
78
-
-
0026451081
-
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
-
Nishizuka, Y. (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
-
(1992)
Science
, vol.258
, pp. 607-614
-
-
Nishizuka, Y.1
-
79
-
-
0028811653
-
Protein kinase C: Structure, function, and regulation
-
Newton, A. C. (1995). Protein kinase C: structure, function, and regulation. J Biol Chem 270, 28495-28498.
-
(1995)
J Biol Chem
, vol.270
, pp. 28495-28498
-
-
Newton, A.C.1
-
80
-
-
0034698182
-
Mitochondrial translocation of protein kinase Cin phorbol ester-induced cytochrome c release and apoptosis
-
Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. (2000). Mitochondrial translocation of protein kinase Cin phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 275(29), 21793-21796.
-
(2000)
J Biol Chem
, vol.275
, Issue.29
, pp. 21793-21796
-
-
Majumder, P.K.1
Pandey, P.2
Sun, X.3
Cheng, K.4
Datta, R.5
Saxena, S.6
Kharbanda, S.7
Kufe, D.8
-
81
-
-
0033233483
-
Protein kinase targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector C?
-
Li, L., Lorenzo, P. S., Bogi, K., Blumberg, P. M. and Yuspa, S. H. (1999). Protein kinase targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector C?. Mol Cell Biol 19, 8547-8558.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 8547-8558
-
-
Li, L.1
Lorenzo, P.S.2
Bogi, K.3
Blumberg, P.M.4
Yuspa, S.H.5
-
82
-
-
0039765390
-
Involvement of protein kinase C(PKC?) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKC?
-
Fujii, T., Garcia-Bermejo, M. L., Bernabo, J. L., Caamano, J., Ohba, M., Kuroki, T., Li, I., Yuspa, S. H., and Kazanietz, M. G. (2000). Involvement of protein kinase C(PKC?) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKC?. J Biol Chem 275, 7574-7582.
-
(2000)
J Biol Chem
, vol.275
, pp. 7574-7582
-
-
Fujii, T.1
Garcia-Bermejo, M.L.2
Bernabo, J.L.3
Caamano, J.4
Ohba, M.5
Kuroki, T.6
Li, I.7
Yuspa, S.H.8
Kazanietz, M.G.9
-
83
-
-
0034741269
-
a against TNF-related apoptosis-inducing ligand (TRAIL)- induced apoptosis in glioma cells
-
a against TNF-related apoptosis-inducing ligand (TRAIL)- induced apoptosis in glioma cells. Biochem Biophys Res Commun 284, 1162-1167.
-
(2001)
Biochem Biophys Res Commun
, vol.284
, pp. 1162-1167
-
-
Shinohara, H.1
Kayagaki, N.2
Yagita, H.3
Oyaizu, N.4
Ohba, M.5
Kuroki, T.6
Ikawa, Y.7
-
84
-
-
0032537024
-
Loss of protein kinase C function induces an apoptotic response
-
Whelan, R. D. and Parker, P. J. (1998). Loss of protein kinase C function induces an apoptotic response. Oncogene 16, 1939-1944.
-
(1998)
Oncogene
, vol.16
, pp. 1939-1944
-
-
Whelan, R.D.1
Parker, P.J.2
-
85
-
-
0037959723
-
Inhibition of PKCinduces a PKC?-dependent apoptotic program in salivary epithelial cells
-
Matassa, A. A., Kalkofen, R. L., Carpenter, L., Biden, T. J., and Reyland, M. E. (2003). Inhibition of PKCinduces a PKC?-dependent apoptotic program in salivary epithelial cells. Cell Death Differ 10, 269-277.
-
(2003)
Cell Death Differ
, vol.10
, pp. 269-277
-
-
Matassa, A.A.1
Kalkofen, R.L.2
Carpenter, L.3
Biden, T.J.4
Reyland, M.E.5
-
86
-
-
0036829593
-
Proteolytic activation of protein kinase Cby caspase-mediated processing and transduction of antiapoptotic signals
-
Basu, A., Lu, D., Sun, B., Moor, A. N., Akkaraju, G. R., and Huang, J. (2002). Proteolytic activation of protein kinase Cby caspase-mediated processing and transduction of antiapoptotic signals. J Biol Chem 277, 41850-41856.
-
(2002)
J Biol Chem
, vol.277
, pp. 41850-41856
-
-
Basu, A.1
Lu, D.2
Sun, B.3
Moor, A.N.4
Akkaraju, G.R.5
Huang, J.6
-
87
-
-
0035976906
-
Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis
-
Gomez-Angelats, M. and Cidlowski, J. A. (2001). Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. J Biol Chem 276, 44944-44952.
-
(2001)
J Biol Chem
, vol.276
, pp. 44944-44952
-
-
Gomez-Angelats, M.1
Cidlowski, J.A.2
-
88
-
-
0035097350
-
Activation of protein kinase C inhibits TRAIL-induced caspases activation mitochondrial events and apoptosis in a human leukemic T cell line
-
Sarker, M., Ruiz-Ruiz, C., and Lopez-Rivas, A. (2001). Activation of protein kinase C inhibits TRAIL-induced caspases activation mitochondrial events and apoptosis in a human leukemic T cell line. Cell Death Differ 8(2), 172-181.
-
(2001)
Cell Death Differ
, vol.8
, Issue.2
, pp. 172-181
-
-
Sarker, M.1
Ruiz-Ruiz, C.2
Lopez-Rivas, A.3
-
89
-
-
0036479137
-
Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain
-
Meng, W. H., Heldebrant, M. P., and Kaufmann, S. H. (2002). Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain. J Biol Chem 277, 3776-3783.
-
(2002)
J Biol Chem
, vol.277
, pp. 3776-3783
-
-
Meng, W.H.1
Heldebrant, M.P.2
Kaufmann, S.H.3
-
90
-
-
0242414715
-
Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling
-
Harper, N., Hughes, M. A., Farrow, S. N., Cohen, G. M., and MacFarlane, M. (2003). Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling. J Biol Chem 278, 44338-44347.
-
(2003)
J Biol Chem
, vol.278
, pp. 44338-44347
-
-
Harper, N.1
Hughes, M.A.2
Farrow, S.N.3
Cohen, G.M.4
MacFarlane, M.5
-
91
-
-
0037142620
-
Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells
-
Sarker, M., Ruiz-Ruiz, C., Robledo, G., and Lopez-Rivas, A. (2002). Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells. Oncogene 21(27), 4323-4327.
-
(2002)
Oncogene
, vol.21
, Issue.27
, pp. 4323-4327
-
-
Sarker, M.1
Ruiz-Ruiz, C.2
Robledo, G.3
Lopez-Rivas, A.4
-
92
-
-
18044363726
-
Variable expression of protein kinase Cin human melanoma cells regulates sensitivity to TRAIL-induced apoptosis
-
Gillespie, S., Zhang, X. D., and Hersey, P. (2005). Variable expression of protein kinase Cin human melanoma cells regulates sensitivity to TRAIL-induced apoptosis. Mol Cancer Ther 4, 668-676.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 668-676
-
-
Gillespie, S.1
Zhang, X.D.2
Hersey, P.3
-
93
-
-
0037418238
-
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
-
Lei, K. and Davis, R. J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100(5), 2432-2437.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.5
, pp. 2432-2437
-
-
Lei, K.1
Davis, R.J.2
-
94
-
-
13944262137
-
JNK is associated with Bcl-2 and PP1 in mitochondria: Paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2
-
Brichese, L., Cazettes, G., and Valette, A. (2004). JNK is associated with Bcl-2 and PP1 in mitochondria: Paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2. Cell Cycle 3(10), 1312-1319.
-
(2004)
Cell Cycle
, vol.3
, Issue.10
, pp. 1312-1319
-
-
Brichese, L.1
Cazettes, G.2
Valette, A.3
-
95
-
-
2442429306
-
JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins
-
Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N., and Gotoh, Y. (2004). JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23(8), 1889-1899.
-
(2004)
EMBO J
, vol.23
, Issue.8
, pp. 1889-1899
-
-
Tsuruta, F.1
Sunayama, J.2
Mori, Y.3
Hattori, S.4
Shimizu, S.5
Tsujimoto, Y.6
Yoshioka, K.7
Masuyama, N.8
Gotoh, Y.9
-
96
-
-
0043091981
-
Selective activation of the c-Jun-N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited
-
Molton, S. A., Todd, D. E., and Cook, S. J. (2003). Selective activation of the c-Jun-N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited. Oncogene 22(30), 4690-4701.
-
(2003)
Oncogene
, vol.22
, Issue.30
, pp. 4690-4701
-
-
Molton, S.A.1
Todd, D.E.2
Cook, S.J.3
-
97
-
-
0034644697
-
The tumor necrosis factor- related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation
-
Muhlenbeck, F., Schneider, P., Bodmer, J. L., Schwenzer, R., Hauser, A., Schubert, G., Scheurich, P., Moosmayer, D., Tschopp, J., and Wajant, H. (2000). The tumor necrosis factor- related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. J Biol Chem 275(41), 32208-32213.
-
(2000)
J Biol Chem
, vol.275
, Issue.41
, pp. 32208-32213
-
-
Muhlenbeck, F.1
Schneider, P.2
Bodmer, J.L.3
Schwenzer, R.4
Hauser, A.5
Schubert, G.6
Scheurich, P.7
Moosmayer, D.8
Tschopp, J.9
Wajant, H.10
-
98
-
-
0033040818
-
JNK/ SAPK activity contributes to TRAIL-induced apoptosis
-
Herr, I., Wilhelm, D., Meyer, E., Jeremias, I., Angel, P., and Debatin, K. M. (1999). JNK/ SAPK activity contributes to TRAIL-induced apoptosis. Cell Death Differ 6(2), 130-135.
-
(1999)
Cell Death Differ
, vol.6
, Issue.2
, pp. 130-135
-
-
Herr, I.1
Wilhelm, D.2
Meyer, E.3
Jeremias, I.4
Angel, P.5
Debatin, K.M.6
-
99
-
-
28844441555
-
Molecular determinants of kinase pathway activation by apo2 ligand/tumor necrosis factor related apoptosis-inducing ligand
-
Varfolomeev, E., Maecker, H., Sharp, D., Lawrence, D., Renz, M., Vucic, D. and Ashkenazi, A. (2005). Molecular determinants of kinase pathway activation by apo2 ligand/tumor necrosis factor related apoptosis-inducing ligand. J Biol Chem 280, 40599-40608.
-
(2005)
J Biol Chem
, vol.280
, pp. 40599-40608
-
-
Varfolomeev, E.1
Maecker, H.2
Sharp, D.3
Lawrence, D.4
Renz, M.5
Vucic, D.6
Ashkenazi, A.7
-
100
-
-
21644438825
-
Ranking the role of RANK ligand in apoptosis
-
Bharti, A. C. and Aggarwal, B. B. (2004). Ranking the role of RANK ligand in apoptosis. Apoptosis 9, 677-690.
-
(2004)
Apoptosis
, vol.9
, pp. 677-690
-
-
Bharti, A.C.1
Aggarwal, B.B.2
-
101
-
-
1542269020
-
Targeting the JNK MAPK cascade for inhibition: Basic science and therapeutic potential
-
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., and Barr, R. K. (2004). Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 1697, 89-101.
-
(2004)
Biochim Biophys Acta
, vol.1697
, pp. 89-101
-
-
Bogoyevitch, M.A.1
Boehm, I.2
Oakley, A.3
Ketterman, A.J.4
Barr, R.K.5
-
102
-
-
33644747383
-
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to TRAIL are more vulnerable to necrotic cell death induced by Cisplatin
-
Zhang, X. D., Wu, J. J., Gillespie, S., Borrow, J. and Hersey, P. (2006). Human melanoma cells selected for resistance to apoptosis by prolonged exposure to TRAIL are more vulnerable to necrotic cell death induced by Cisplatin. Clin Cancer Res 12, 1355-1364.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1355-1364
-
-
Zhang, X.D.1
Wu, J.J.2
Gillespie, S.3
Borrow, J.4
Hersey, P.5
-
103
-
-
2642536197
-
-
Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q., and Thompson, C. B. (2004). Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18(11), 1272-1282. 103a. Mhaidat, N. M., Zhang, X. D., Jiang, C. C., and Hersey, P. (2007). Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin cancer Res 13, 1308-1314.
-
Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q., and Thompson, C. B. (2004). Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18(11), 1272-1282. 103a. Mhaidat, N. M., Zhang, X. D., Jiang, C. C., and Hersey, P. (2007). Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin cancer Res 13, 1308-1314.
-
-
-
-
104
-
-
20044382799
-
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
-
Strumberg, D., Richly, H., Hilger, R. A., Schleucher, N., Korfee, S., Tewes, M., Faghih, M., Brendel, E., Voliotis, D., Haase, C. G., Schwartz, B., Awada, A., Voigtmann, R., Scheulen, M. E., and Seeber, S. (2005). Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol 23(5), 965-972.
-
(2005)
J Clin Oncol
, vol.23
, Issue.5
, pp. 965-972
-
-
Strumberg, D.1
Richly, H.2
Hilger, R.A.3
Schleucher, N.4
Korfee, S.5
Tewes, M.6
Faghih, M.7
Brendel, E.8
Voliotis, D.9
Haase, C.G.10
Schwartz, B.11
Awada, A.12
Voigtmann, R.13
Scheulen, M.E.14
Seeber, S.15
-
105
-
-
23944439944
-
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies
-
LoRusso, P. M., Adjei, A. A., Varterasian, M., Gadgeel, S., Reid, J., Mitchell, D. Y., Hanson, L., DeLuca, P., Bruzek, L., Piens, J., Asbury, P., VanBecelaere, K., Herrera, R., Sebolt-Leopold, J., and Meyer, M. B. (2005). Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. J Clin Oncol 23(23), 5281-5293.
-
(2005)
J Clin Oncol
, vol.23
, Issue.23
, pp. 5281-5293
-
-
LoRusso, P.M.1
Adjei, A.A.2
Varterasian, M.3
Gadgeel, S.4
Reid, J.5
Mitchell, D.Y.6
Hanson, L.7
DeLuca, P.8
Bruzek, L.9
Piens, J.10
Asbury, P.11
VanBecelaere, K.12
Herrera, R.13
Sebolt-Leopold, J.14
Meyer, M.B.15
-
106
-
-
0035132538
-
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro
-
End, D. W., Smets, G., Todd, A. V., Applegate, T. L., Fuery, C. J., Angibaud, P., Venet, M., Sanz, G., Poignet, H., Skrzat, S., Devine, A., Wouters, W., and Bowden, C. (2001). Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res 61(1), 131-137.
-
(2001)
Cancer Res
, vol.61
, Issue.1
, pp. 131-137
-
-
End, D.W.1
Smets, G.2
Todd, A.V.3
Applegate, T.L.4
Fuery, C.J.5
Angibaud, P.6
Venet, M.7
Sanz, G.8
Poignet, H.9
Skrzat, S.10
Devine, A.11
Wouters, W.12
Bowden, C.13
-
107
-
-
0035283895
-
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase., BIM- 46228
-
Prevost, G. P., Pradines, A., Brezak, M. C., Lonchampt, M. O., Viossat, I., Ader, I., Toulas, C., Kasprzyk, P., Gordon, T., Favre, G. and Morgan, B. (2001). Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase., BIM- 46228. Int J Cancer 91(5), 718-722.
-
(2001)
Int J Cancer
, vol.91
, Issue.5
, pp. 718-722
-
-
Prevost, G.P.1
Pradines, A.2
Brezak, M.C.3
Lonchampt, M.O.4
Viossat, I.5
Ader, I.6
Toulas, C.7
Kasprzyk, P.8
Gordon, T.9
Favre, G.10
Morgan, B.11
-
108
-
-
0037431539
-
-
Smalley, K. S. and Eisen, T. G. (2003). Farnesyl transferase inhibitor SCH66336 is cytostatic pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells. Int J Cancer 105(2), 165-175. 108a. Wang, Y.F., Jiang, C. C., Kiejda, K. A., Gillespie, S., Zhang, X. D., and Hersey, P. (2007). Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK is Caspase- Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1. Clin Cancer Res.
-
Smalley, K. S. and Eisen, T. G. (2003). Farnesyl transferase inhibitor SCH66336 is cytostatic pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells. Int J Cancer 105(2), 165-175. 108a. Wang, Y.F., Jiang, C. C., Kiejda, K. A., Gillespie, S., Zhang, X. D., and Hersey, P. (2007). Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK is Caspase- Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1. Clin Cancer Res.
-
-
-
-
109
-
-
4444223702
-
Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3- kinase signaling
-
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., Kirkpatrick, L. and Powis, G. (2004). Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3- kinase signaling. Mol Cancer Ther 3(7), 763-772.
-
(2004)
Mol Cancer Ther
, vol.3
, Issue.7
, pp. 763-772
-
-
Ihle, N.T.1
Williams, R.2
Chow, S.3
Chew, W.4
Berggren, M.I.5
Paine-Murrieta, G.6
Minion, D.J.7
Halter, R.J.8
Wipf, P.9
Abraham, R.10
Kirkpatrick, L.11
Powis, G.12
-
110
-
-
21244466289
-
Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: Effects on Hsp90 and client proteins in melanoma models
-
Smith, V., Sausville, E. A., Camalier, R. F., Fiebig, H. H., and Burger, A. M. (2005). Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models. Cancer Chemother Pharmacol 56(2), 126-137.
-
(2005)
Cancer Chemother Pharmacol
, vol.56
, Issue.2
, pp. 126-137
-
-
Smith, V.1
Sausville, E.A.2
Camalier, R.F.3
Fiebig, H.H.4
Burger, A.M.5
-
111
-
-
24944546195
-
Heat shock protein 90 indirectly regulates ERK activity by affecting Raf protein metabolism
-
Dou, F., Yuan, L. D., and Zhu, J. J. (2005). Heat shock protein 90 indirectly regulates ERK activity by affecting Raf protein metabolism. Acta Biochim Biophys Sin 37(7), 501-505.
-
(2005)
Acta Biochim Biophys Sin
, vol.37
, Issue.7
, pp. 501-505
-
-
Dou, F.1
Yuan, L.D.2
Zhu, J.J.3
-
112
-
-
64549154230
-
-
Tang, H. J., Jin, X., Wang, S., Yang, D., Cao, Y., Chen, J., Gossett, D. R. and Lin, J. (2005). A small molecule compound inhibits AKT pathway in ovarian cancer cell lines. Gynecol. Oncol. Oct 3 (epub ahead of print).
-
Tang, H. J., Jin, X., Wang, S., Yang, D., Cao, Y., Chen, J., Gossett, D. R. and Lin, J. (2005). A small molecule compound inhibits AKT pathway in ovarian cancer cell lines. Gynecol. Oncol. Oct 3 (epub ahead of print).
-
-
-
-
113
-
-
23844476134
-
CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium
-
Margolin, K., Longmate, J., Baratta, T., Synold, T., Christensen, S., Weber, J., Gajewski, T., Quirt, I., and Doroshow, J. H. (2005). CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer 104(5), 1045-1048.
-
(2005)
Cancer
, vol.104
, Issue.5
, pp. 1045-1048
-
-
Margolin, K.1
Longmate, J.2
Baratta, T.3
Synold, T.4
Christensen, S.5
Weber, J.6
Gajewski, T.7
Quirt, I.8
Doroshow, J.H.9
-
114
-
-
9644252848
-
Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells
-
Romano, M. F., Avellino, R., Petrella, A., Bisogni, R., Romano, S., and Venuta, S. (2004). Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells, Eur J Cancer 40(18), 2829-2836.
-
(2004)
Eur J Cancer
, vol.40
, Issue.18
, pp. 2829-2836
-
-
Romano, M.F.1
Avellino, R.2
Petrella, A.3
Bisogni, R.4
Romano, S.5
Venuta, S.6
-
115
-
-
3142745263
-
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: Implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
-
Amiri, K. I., Horton, L. W., LaFleur, B. J., Sosman, J. A., and Richmond, A. (2004). Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res 64(14), 4912-4918.
-
(2004)
Cancer Res
, vol.64
, Issue.14
, pp. 4912-4918
-
-
Amiri, K.I.1
Horton, L.W.2
LaFleur, B.J.3
Sosman, J.A.4
Richmond, A.5
-
116
-
-
4444300254
-
Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells
-
Munshi, A., Kurland, J. F., Nishikawa, T., Chiao, P. J., Andreeff, M., and Meyn, R. E. (2004). Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells. Mol Cancer Ther 3(8), 985-992.
-
(2004)
Mol Cancer Ther
, vol.3
, Issue.8
, pp. 985-992
-
-
Munshi, A.1
Kurland, J.F.2
Nishikawa, T.3
Chiao, P.J.4
Andreeff, M.5
Meyn, R.E.6
-
117
-
-
23444449848
-
Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/ mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway
-
Siwak, D. R., Shishodia, S., Aggarwal, B. B., and Kurzrock, R. (2005). Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/ mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104(4), 879-890.
-
(2005)
Cancer
, vol.104
, Issue.4
, pp. 879-890
-
-
Siwak, D.R.1
Shishodia, S.2
Aggarwal, B.B.3
Kurzrock, R.4
-
118
-
-
0036829335
-
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study
-
and National Cancer Institute of Canada Clinical Trials Group
-
Tozer, R. G., Burdette-Radoux, S., Berlanger, K., Davis, M. L., Lohmann, R. C., Rusthoven, J. R., Wainman, N., Zee, B., Seymour, L. and National Cancer Institute of Canada Clinical Trials Group. (2002). A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs 20(4), 407-412.
-
(2002)
Invest New Drugs
, vol.20
, Issue.4
, pp. 407-412
-
-
Tozer, R.G.1
Burdette-Radoux, S.2
Berlanger, K.3
Davis, M.L.4
Lohmann, R.C.5
Rusthoven, J.R.6
Wainman, N.7
Zee, B.8
Seymour, L.9
-
119
-
-
0035035103
-
Phase II evaluation of bryostatin-1 in metastatic melanoma
-
Bedikian, A. Y., Plager, C., Stewart, J. R., O'Brian, C. A., Herdman, S. K., Ross, M., Papadopoulos, N., Eton, O., Ellerhorst, J., and Smith, T. (2001). Phase II evaluation of bryostatin-1 in metastatic melanoma. Melanoma Res 11(2), 183-188.
-
(2001)
Melanoma Res
, vol.11
, Issue.2
, pp. 183-188
-
-
Bedikian, A.Y.1
Plager, C.2
Stewart, J.R.3
O'Brian, C.A.4
Herdman, S.K.5
Ross, M.6
Papadopoulos, N.7
Eton, O.8
Ellerhorst, J.9
Smith, T.10
-
120
-
-
9144226837
-
A phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma
-
Advani, R., Peethambaram, P., Lum, B. L., Fisher, G. A., Hartmann, L., Long, H. J., Halsey, J., Holmlund, J. T., Dorr, A. and Sikic, B. I. (2004). A phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma. Cancer 100(2), 321-326.
-
(2004)
Cancer
, vol.100
, Issue.2
, pp. 321-326
-
-
Advani, R.1
Peethambaram, P.2
Lum, B.L.3
Fisher, G.A.4
Hartmann, L.5
Long, H.J.6
Halsey, J.7
Holmlund, J.T.8
Dorr, A.9
Sikic, B.I.10
-
121
-
-
0036134037
-
Protein kinase C inhibitors
-
Swannie, H. C. and Kaye, S. B. (2002). Protein kinase C inhibitors. Curr Oncol Rep 4(1), 37-46.
-
(2002)
Curr Oncol Rep
, vol.4
, Issue.1
, pp. 37-46
-
-
Swannie, H.C.1
Kaye, S.B.2
-
122
-
-
23044464191
-
RACK1 mediates activation of JNK by protein kinase C
-
Lopez-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L. H., and Ronai, Z. (2005). RACK1 mediates activation of JNK by protein kinase C. Mol Cell 19(3), 309-320.
-
(2005)
Mol Cell
, vol.19
, Issue.3
, pp. 309-320
-
-
Lopez-Bergami, P.1
Habelhah, H.2
Bhoumik, A.3
Zhang, W.4
Wang, L.H.5
Ronai, Z.6
-
123
-
-
4444239987
-
The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells
-
Zhang, X. D., Gillespie, S. K., Borrow, J. M., and Hersey, P. (2004). The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol Cancer Ther 3(4), 425-435.
-
(2004)
Mol Cancer Ther
, vol.3
, Issue.4
, pp. 425-435
-
-
Zhang, X.D.1
Gillespie, S.K.2
Borrow, J.M.3
Hersey, P.4
-
124
-
-
26444439216
-
Prospects: Histone deacetylase inhibitors
-
Dokmanovic, M. and Marks, P. A. (2005). Prospects: histone deacetylase inhibitors. J Cell Biochem 96(2), 293-304.
-
(2005)
J Cell Biochem
, vol.96
, Issue.2
, pp. 293-304
-
-
Dokmanovic, M.1
Marks, P.A.2
-
125
-
-
0035291880
-
Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis
-
Nguyen, T., Zhang, X. D. and Hersey, P. (2001). Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis. Clin Cancer Res 7 (Suppl 3), 966s-973s.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.SUPPL. 3
-
-
Nguyen, T.1
Zhang, X.D.2
Hersey, P.3
-
126
-
-
33646706237
-
Regulation of trail receptor expression in human melanoma
-
ed. el-Deiry W. S. Humana Press, Totowa, NJ, pp
-
Hersey, P., Zhang, S. Y. and Zhang, X. D. (2005). Regulation of trail receptor expression in human melanoma. In: Cancer Drug Discovery and Development: Death Receptors in Cancer Therapy, ed. el-Deiry W. S. Humana Press, Totowa, NJ, pp. 175-187.
-
(2005)
Cancer Drug Discovery and Development: Death Receptors in Cancer Therapy
, pp. 175-187
-
-
Hersey, P.1
Zhang, S.Y.2
Zhang, X.D.3
-
127
-
-
1642290640
-
Translational control of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor expression in melanoma cells
-
Zhang, X. Y., Zhang, X. D., Borrow, J. M., Nguyen, T. and Hersey, P. (2004). Translational control of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor expression in melanoma cells. J Biol Chem 279, 10606-10614.
-
(2004)
J Biol Chem
, vol.279
, pp. 10606-10614
-
-
Zhang, X.Y.1
Zhang, X.D.2
Borrow, J.M.3
Nguyen, T.4
Hersey, P.5
-
128
-
-
4143115887
-
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
-
Jin, Z., McDonald, E. R., III, Dicker, D. T. and el-Deiry, W. S. (2004). Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279(34), 35829-35239.
-
(2004)
J Biol Chem
, vol.279
, Issue.34
, pp. 35829-35239
-
-
Jin, Z.1
McDonald III, E.R.2
Dicker, D.T.3
el-Deiry, W.S.4
-
129
-
-
22244472001
-
Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells
-
Shiraishi, T., Yoshida, T., Nakata, S., Horinaka, M., Wakada, M., Mizutani, Y., Miki, T., and Sakai, T. (2005). Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res 65(14), 6364-6370.
-
(2005)
Cancer Res
, vol.65
, Issue.14
, pp. 6364-6370
-
-
Shiraishi, T.1
Yoshida, T.2
Nakata, S.3
Horinaka, M.4
Wakada, M.5
Mizutani, Y.6
Miki, T.7
Sakai, T.8
-
130
-
-
20444486559
-
-
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042), 677-681.
-
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042), 677-681.
-
-
-
-
131
-
-
20444456293
-
Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines
-
Karl, E., Warner, K., Zeitlin, B., Kaneko, T., Wurtzel, L., Jin, T., Chang, J., Wang, S., Wang, C. Y., Strieter, R. M., Nunez, G., Polverini, P. J., and Nor, J. E. (2005). Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Res 65(12), 5063-5069.
-
(2005)
Cancer Res
, vol.65
, Issue.12
, pp. 5063-5069
-
-
Karl, E.1
Warner, K.2
Zeitlin, B.3
Kaneko, T.4
Wurtzel, L.5
Jin, T.6
Chang, J.7
Wang, S.8
Wang, C.Y.9
Strieter, R.M.10
Nunez, G.11
Polverini, P.J.12
Nor, J.E.13
-
132
-
-
13944262237
-
-
Oliver, C. L., Miranda, M. B., Shangary, S., Land, S., Wang, S., and Johnson, D. E. (2005). (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther 4(1), 23-31.
-
Oliver, C. L., Miranda, M. B., Shangary, S., Land, S., Wang, S., and Johnson, D. E. (2005). (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther 4(1), 23-31.
-
-
-
-
133
-
-
0034684471
-
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
-
Jansen, B., Wacheck, V., Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., and Pehamberger, H. (2000). Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356(9243), 1728-1733.
-
(2000)
Lancet
, vol.356
, Issue.9243
, pp. 1728-1733
-
-
Jansen, B.1
Wacheck, V.2
Heere-Ress, E.3
Schlagbauer-Wadl, H.4
Hoeller, C.5
Lucas, T.6
Hoermann, M.7
Hollenstein, U.8
Wolff, K.9
Pehamberger, H.10
-
134
-
-
33750600634
-
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The Oblimersen Melanoma Study Group
-
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006). Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol 24, 4738-4745.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4738-4745
-
-
Bedikian, A.Y.1
Millward, M.2
Pehamberger, H.3
Conry, R.4
Gore, M.5
Trefzer, U.6
Pavlick, A.C.7
DeConti, R.8
Hersh, E.M.9
Hersey, P.10
-
135
-
-
0034096268
-
A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xLexpression efficiently induces apoptosis in tumor cells
-
Zangemeister-Wittke, U., Leech, S. H., Olie, R. A., Simoes-Wust, A. P., Gautschi, O., Luedke, G. H., Natt, F., Haner, R., Martin, P., Hall, J., Nalin, C. M., and Stahel, R. A. (2000). A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xLexpression efficiently induces apoptosis in tumor cells. Clin Cancer Res 6(6), 2547-2555.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.6
, pp. 2547-2555
-
-
Zangemeister-Wittke, U.1
Leech, S.H.2
Olie, R.A.3
Simoes-Wust, A.P.4
Gautschi, O.5
Luedke, G.H.6
Natt, F.7
Haner, R.8
Martin, P.9
Hall, J.10
Nalin, C.M.11
Stahel, R.A.12
-
136
-
-
0036568524
-
Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy
-
Heere-Ress, E., Thallinger, C., Lucas, T., Schlagbauer-Wadl, H., Wacheck, V., Monia, B. P., Wolff, K., Pehamberger, H., and Jansen, B. (2002). Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. Int J Cancer 99(1), 29-34.
-
(2002)
Int J Cancer
, vol.99
, Issue.1
, pp. 29-34
-
-
Heere-Ress, E.1
Thallinger, C.2
Lucas, T.3
Schlagbauer-Wadl, H.4
Wacheck, V.5
Monia, B.P.6
Wolff, K.7
Pehamberger, H.8
Jansen, B.9
-
137
-
-
1642482625
-
Small interfering RNA targeting bcl-2 sensitizes malignant melanoma
-
Wacheck, V., Losert, D., Gunsberg, P., Vornlocher, H. P., Hadwiger, P., Geick, A., Pehamberger, H., Muller, M., and Jansen, B. (2003). Small interfering RNA targeting bcl-2 sensitizes malignant melanoma. Oligonucleotides 13(5), 393-400.
-
(2003)
Oligonucleotides
, vol.13
, Issue.5
, pp. 393-400
-
-
Wacheck, V.1
Losert, D.2
Gunsberg, P.3
Vornlocher, H.P.4
Hadwiger, P.5
Geick, A.6
Pehamberger, H.7
Muller, M.8
Jansen, B.9
-
138
-
-
3042570258
-
Mcl-1 is a novel therapeutic target for human sarcoma: Synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide
-
Thallinger, C., Wolschek, M. F., Maierhofer, H., Skvara, H., Pehamberger, H., Monia, B. P., Jansen, B., Wacheck, V., and Selzer, E. (2004). Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide. Clin Cancer Res 10(12 Pt 1), 4185-4191.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.12 PART 1
, pp. 4185-4191
-
-
Thallinger, C.1
Wolschek, M.F.2
Maierhofer, H.3
Skvara, H.4
Pehamberger, H.5
Monia, B.P.6
Jansen, B.7
Wacheck, V.8
Selzer, E.9
-
139
-
-
9144234685
-
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
-
Schimmer, A. D., Welsh, K., Pinilla, C., Wang, Z., Krajewska, M., Bonneau, M. J., Pedersen, I. M., Kitada, S., Scott, E. L., Bailly-Maitre, B., Glinsky, G., Scudiero, D., Sausville, E., Salvesen, G., Nefzi, A., Ostresh, J. M., Houghten, R. A., and Reed, J. C. (2004). Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5(1), 25-35.
-
(2004)
Cancer Cell
, vol.5
, Issue.1
, pp. 25-35
-
-
Schimmer, A.D.1
Welsh, K.2
Pinilla, C.3
Wang, Z.4
Krajewska, M.5
Bonneau, M.J.6
Pedersen, I.M.7
Kitada, S.8
Scott, E.L.9
Bailly-Maitre, B.10
Glinsky, G.11
Scudiero, D.12
Sausville, E.13
Salvesen, G.14
Nefzi, A.15
Ostresh, J.M.16
Houghten, R.A.17
Reed, J.C.18
-
140
-
-
0036341291
-
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
-
Fulda, S., Wick, W., Weller, M., and Debatink, K. M. (2002). Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8(8), 808-815.
-
(2002)
Nat Med
, vol.8
, Issue.8
, pp. 808-815
-
-
Fulda, S.1
Wick, W.2
Weller, M.3
Debatink, K.M.4
-
141
-
-
0347895102
-
Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ
-
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., and Kaufmann, S. H. (2002). Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 277(46), 44236-44243.
-
(2002)
J Biol Chem
, vol.277
, Issue.46
, pp. 44236-44243
-
-
Arnt, C.R.1
Chiorean, M.V.2
Heldebrant, M.P.3
Gores, G.J.4
Kaufmann, S.H.5
-
142
-
-
0036565885
-
Ectopic overexpression of second mitochondria- derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/ TRAIL-induced apoptosis
-
Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., and Bhalla, K. (2002). Ectopic overexpression of second mitochondria- derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/ TRAIL-induced apoptosis. Blood 99(9), 3419-3426.
-
(2002)
Blood
, vol.99
, Issue.9
, pp. 3419-3426
-
-
Guo, F.1
Nimmanapalli, R.2
Paranawithana, S.3
Wittman, S.4
Griffin, D.5
Bali, P.6
O'Bryan, E.7
Fumero, C.8
Wang, H.G.9
Bhalla, K.10
-
143
-
-
34250888209
-
Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response
-
Jiang, C. C., Chen, L. H., Gillespie, S., Kiejda, K. A., Mhaidat, N., Wang, Y. F., Thorne, R., Zhang, X. D., and Hersey, P. (2007). Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer research 67, 5880-5888.
-
(2007)
Cancer research
, vol.67
, pp. 5880-5888
-
-
Jiang, C.C.1
Chen, L.H.2
Gillespie, S.3
Kiejda, K.A.4
Mhaidat, N.5
Wang, Y.F.6
Thorne, R.7
Zhang, X.D.8
Hersey, P.9
-
144
-
-
64549125818
-
-
Zhu et al. Activation of JNK is a mediator of Vincristine-induced apoptosis in melanoma cells, under editorial review
-
Zhu et al. Activation of JNK is a mediator of Vincristine-induced apoptosis in melanoma cells, under editorial review.
-
-
-
|